AQP7 and metabolic syndrome: Impaired AQP7 expression in adipocytes contributes to dyslipidemia and lipotoxicity, while defective glycerol transport via AQP7 aggravates insulin resistance and ectopic lipid deposition, linking metabolic imbalance to DKD progression (122).